PDB39 EVALUATION OF THE COST-UTILITY OF INSULIN DETEMIR COMPARED TO INSULIN GLARGINE, BOTH IN COMBINATION WITH INSULIN ASPART INTYPE-I DIABETES IN GERMANY AND AUSTRIA
Abstract
Authors
S Roze KU Wittrup-Jensen WJ Valentine AJ Palmer